GLP-1 (semaglutide or tirzepatide) Therapy in Older Adults: Balancing Benefit & Risk Beyond Age 65 Joshua Silva, MD Dec 12, 2025 4 min read Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Last clinically updated: December 2025 Many discussions about GLP-1 medications in older adults come from friends, family, or acquaintances , as well as online forums, news stories, and social media posts
The eosinophil in infection
We help connect these start-ups to big companies, so they can begin to incorporate them into portfolios. Overall, May says, the goal is to highlight the potential of combining new ingredient technologies with existing solutions. At Mistas Healthy Nutrition Symposium in March, representatives from 60 companies came to its labs to tackle some of the challenges raised by the GLP-1 and UPF trends
Marx N, Federici M, Schutt K, et al